We are live on
!
Find out more
Parnassus Investments Portfolio holdings
AUM
$37.4B
1-Year Est. Return
35.42%
This Fund
S&P 500
This Quarter
Est. Return
+7.73%
1 Year Est. Return
+35.42%
3 Year Est. Return
+106.24%
5 Year Est. Return
+128.96%
10 Year Est. Return
+492.3%
AUM
$11.4B
AUM Growth
+$1.06B
(+10%)
Cap. Flow
+$332M
Cap. Flow
% of AUM
2.9%
Top 10 Holdings %
Top 10 Hldgs %
31.94%
Holding
114
New
5
Increased
59
Reduced
24
Closed
4
Avg Time Held
3.5
quarters
Top 10 Avg Time Held
3
quarters
Top 20 Avg Time Held
2.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Patterson Companies, Inc.
PDCO
|
+$95M |
| 2 |
United Parcel Service
UPS
|
+$84.6M |
| 3 |
Verisk Analytics
VRSK
|
+$64.4M |
| 4 |
Pentair
PNR
|
+$57.3M |
| 5 |
Gilead Sciences
GILD
|
+$56.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$119M |
| 2 |
W&T Offshore
WTI
|
+$107M |
| 3 |
RVBD
RIVERBED TECHNOLOGY, INC COM
RVBD
|
+$96.2M |
| 4 |
C.H. Robinson
CHRW
|
+$83.2M |
| 5 |
MCRS
MICROS SYSTEMS INC
MCRS
|
+$32.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 20.01% |
| 2 | Technology | 18.03% |
| 3 | Healthcare | 15.82% |
| 4 | Consumer Staples | 12.66% |
| 5 | Energy | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Applied Materials
AMAT
$368B
| $480M | 4.2% |
21,271,650
+54,181
| +0.3% | +$1.11M |
2013 Q2
4 quarters
|
|
|
AGN
2
DELISTED
Allergan Inc
AGN
| $464M | 4.07% |
2,743,352
+100,188
| +4% | +$15.6M |
2013 Q4
2 quarters
|
|
3
Apple
AAPL
$4.98T
| $433M | 3.79% |
18,619,680
-1,323,656
| -7% | -$28.2M |
2013 Q2
4 quarters
|
|
4
Mondelez International
MDLZ
$78.5B
| $346M | 3.03% |
9,195,771
+35,387
| +0.4% | +$1.29M |
2013 Q2
4 quarters
|
|
5
Procter & Gamble
PG
$355B
| $343M | 3% |
4,359,837
+467,695
| +12% | +$37.7M |
2013 Q2
4 quarters
|
|
6
Motorola Solutions
MSI
$74.3B
| $336M | 2.94% |
5,043,365
+170,382
| +3% | +$11.2M |
2013 Q2
4 quarters
|
|
7
Qualcomm
QCOM
$189B
| $330M | 2.89% |
4,172,871
+401,696
| +11% | +$31.9M |
2013 Q2
4 quarters
|
|
|
8
C.H. Robinson
CHRW
$16.1B
| $320M | 2.8% |
5,010,850
-1,415,743
| -22% | -$83.2M |
2013 Q2
4 quarters
|
|
9
Xylem
XYL
$23.9B
| $304M | 2.66% |
7,783,786
+21,400
| +0.3% | +$800K |
2013 Q3
3 quarters
|
|
|
10
Pentair
PNR
$8.45B
| $293M | 2.56% |
6,042,292
+1,126,568
| +23% | +$57.3M |
2013 Q2
4 quarters
|
|
|
11
Gilead Sciences
GILD
$183B
| $279M | 2.44% |
3,363,296
+725,109
| +27% | +$56.4M |
2013 Q2
4 quarters
|
|
12
NOV
NOV
$6.76B
| $278M | 2.43% |
3,374,544
+203,642
| +6% | +$15.2M |
2013 Q2
4 quarters
|
|
|
13
DELISTED
Patterson Companies, Inc.
PDCO
| $277M | 2.43% |
7,011,798
+2,348,892
| +50% | +$95M |
2013 Q2
4 quarters
|
|
14
Iron Mountain
IRM
$34.1B
| $272M | 2.38% |
8,294,044
+532,755
| +7% | +$14.5M |
2013 Q2
4 quarters
|
|
15
CVS Health
CVS
$112B
| $267M | 2.34% |
3,538,361
+374,100
| +12% | +$28.3M |
2013 Q2
4 quarters
|
|
16
PepsiCo
PEP
$173B
| $265M | 2.32% |
2,971,121
+12,100
| +0.4% | +$1.04M |
2013 Q2
4 quarters
|
|
17
DELISTED
Praxair Inc
PX
| $263M | 2.3% |
1,976,681
+371,500
| +23% | +$48.7M |
2013 Q2
4 quarters
|
|
18
Expeditors International
EXPD
$25.4B
| $262M | 2.3% |
5,936,792
+22,200
| +0.4% | +$955K |
2013 Q2
4 quarters
|
|
19
Thomson Reuters
TRI
$45.6B
| $260M | 2.27% |
6,156,101
+935,646
| +18% | +$38.3M |
2013 Q2
4 quarters
|
|
|
SJR
20
DELISTED
Shaw Communications Inc.
SJR
| $254M | 2.23% |
9,917,713
+325,764
| +3% | +$8.01M |
2013 Q2
4 quarters
|
|
21
Sysco
SYY
$38.9B
| $252M | 2.21% |
6,735,296
+1,052,404
| +19% | +$38.6M |
2013 Q2
4 quarters
|
|
|
22
United Parcel Service
UPS
$80.6B
| $246M | 2.16% |
2,399,446
+842,416
| +54% | +$84.6M |
2013 Q2
4 quarters
|
|
23
Novartis
NVS
$271B
| $246M | 2.15% |
3,027,831
+481,473
| +19% | +$37.9M |
2013 Q2
4 quarters
|
|
24
DELISTED
QUESTAR CORP
STR
| $232M | 2.03% |
9,358,087
-113,010
| -1% | -$2.68M |
2013 Q2
4 quarters
|
|
25
Compass Minerals
CMP
$975M
| $230M | 2.01% |
2,398,034
-219,574
| -8% | -$19.8M |
2013 Q2
4 quarters
|
|
Similar funds
ECSS
PIF
TWC
Parnassus Investments's Q2 2014 Portfolio in Review
As of Q2 2014, Parnassus Investments held 114 positions worth $11.4B, up 10% from $10.4B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Parnassus Investments's Q2 2014 filing shows 5 new, 59 increased, 24 reduced and 4 closed positions. Its largest new stake was GenMark Diagnostics, Inc: 2,118,127 shares worth $28.7M. The largest sale was Target, an estimated $119M.
By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.
- Parnassus Investments's largest Q2 2014 buy was GenMark Diagnostics, Inc: 2,118,127 shares worth $28.7M.
- Parnassus Investments added most to Patterson Companies, Inc. in Q2 2014, an estimated $95M increase.
- Parnassus Investments's biggest Q2 2014 reduction was Target, cutting an estimated $119M.
- Parnassus Investments fully exited W&T Offshore in Q2 2014, selling an estimated $107M.
- Parnassus Investments's ten largest holdings make up 32% of its $11.4B portfolio in Q2 2014.
- Parnassus Investments opened 5 new positions and closed 4 in Q2 2014.
- Parnassus Investments's portfolio value rose 10% quarter-over-quarter to $11.4B.
Based on Parnassus Investments's 13F filing for Q2 2014, filed 25 Jul 2014.